domingo, 9 de septiembre de 2018

US insulin price hikes prove fatal for diabetics

US insulin price hikes prove fatal for diabetics

Bioedge

US insulin price hikes prove fatal for diabetics
     
Price increases to insulin in the United States have sparked public outcry, with some reports suggesting that diabetics are now rationing their injections to save money.
NPR recently reported on the tragic case of a 26-year-old diabetic man in Minnesota who died in his apartment in June 2017 after apparently rationing his insulin injections. The man, Alec Smith, had recently aged out of his parents’ health insurance policy, and was ineligible for state health insurance subsidies for his medication. Smith was earning less than $3000 a month, and was unable to cover the $1300 monthly cost of his insulin supplies.
Smith’s mother Nicole Smith-Holt is now campaigning to have the cost of the drugs slashed.
“The price of insulin has gone up over 1,200 percent in 20 years,” Smith-Holt told the Star Tribune earlier this year. “It’s not affordable. You’re price-gouging people who need this one product to live, to survive”.
The American Diabetes Association estimates that diabetics spend about $16,000on health care annually, which is 2.3 times more than a person without diabetes would spend.
Victoria Gagliardo-Silver, a New York based writer and student, slammed Congress for inaction on the issue:
“It is absolutely shameful that in America, a developed country that is capable of spending over half of its federal spending budget on the military and only a measly six percent on health care allows people to die slow, painful, preventable deaths because medical care is too expensive”.  
States have attempted to introduce legislation that requires drug companies to justify price increases for prescription medicine, but the changes have been met with fierce opposition.
Bioedge

Sunday, September 9, 2018 

John Robertson was an American scholar in law and bioethics who died last year. He is best known for making a strong case for “procreative liberty”, whether procreation takes place naturally or with the help of technology. As a tribute to his influence, the current issue of the Journal of Law and the Biosciences contains several articles about this theory.

Robertson’s theme was that reproductive choices which do not harm the interests of others should not be subject to regulation or prohibition. In his best-known book, Children of Choice, published in 1996, he discussed abortion, IVF, surrogacy and pre-natal genetic modification. But time has moved on. The principle of effectively unconstrained “procreative liberty” is being used to justify other developments, some of which are discussed in the Journal, including unisex gestation.

What I found interesting was that Robertson, in a paper written not long before his death, agreed that a male pregnancy (after a womb transplant) could be ethically justified, but only if it were necessary for genetic reproduction. Even he wanted to draw a line somewhere.

However, the author of one of tribute essays questions this restriction. Enjoying the experience of gestation is reason enough, she says. (See below). I suppose that this raises the question of whether it is possible to draw any lines, anywhere, once we agree that reproductive rights should not be limited.

 
m.png
Michael Cook
Editor
BioEdge
 Comment on BioedgeFind Us on FacebookFollow us on Twitter
NEWS THIS WEEK
by Michael Cook | Sep 08, 2018
Supporters want to extend its funding 
 
 
by Michael Cook | Sep 08, 2018
With womb transplants on the way, we have to ask the question 
 
 
by Xavier Symons | Sep 08, 2018
A pregnant Jehovah's Witness teenager had refused the procedure
 
 
by Xavier Symons | Sep 08, 2018
Diabetics are rationing insulin injections. 
 
 
by Xavier Symons | Sep 08, 2018
Doctors at the Moscow clinic cooperated with the woman's request. 
 
 
by Michael Cook | Sep 08, 2018
How does one choose amongst 10,000 options? 
 
 
by Michael Cook | Sep 08, 2018
Nearly 40 people have died in 2018 
 
 
by Michael Cook | Sep 08, 2018
Larger studies are needed to confirm results 
 
 
by Michael Cook | Sep 08, 2018
Mohammed al-Bardan explains to the New York Times why he cares for patients in a rebel-held district of Syria  
BioEdge
Suite 12A, Level 2 | 5 George St | North Strathfield NSW 2137 | Australia
Phone: +61 2 8005 8605
Mobile: 0422-691-615

No hay comentarios: